248 related articles for article (PubMed ID: 34415295)
1. An integrated computational pipeline for designing high-affinity nanobodies with expanded genetic codes.
Padhi AK; Kumar A; Haruna KI; Sato H; Tamura H; Nagatoishi S; Tsumoto K; Yamaguchi A; Iraha F; Takahashi M; Sakamoto K; Zhang KYJ
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34415295
[TBL] [Abstract][Full Text] [Related]
2. Structural and Computational Studies of the SARS-CoV-2 Spike Protein Binding Mechanisms with Nanobodies: From Structure and Dynamics to Avidity-Driven Nanobody Engineering.
Verkhivker G
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328351
[TBL] [Abstract][Full Text] [Related]
3. Affinity enhancement of nanobody binding to EGFR: in silico site-directed mutagenesis and molecular dynamics simulation approaches.
Farasat A; Rahbarizadeh F; Hosseinzadeh G; Sajjadi S; Kamali M; Keihan AH
J Biomol Struct Dyn; 2017 Jun; 35(8):1710-1728. PubMed ID: 27691399
[TBL] [Abstract][Full Text] [Related]
4. A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies.
Chen X; Gentili M; Hacohen N; Regev A
Nat Commun; 2021 Sep; 12(1):5506. PubMed ID: 34535642
[TBL] [Abstract][Full Text] [Related]
5. Nanobody affinity improvement: Directed evolution of the anti-ochratoxin A single domain antibody.
Wang X; Chen Q; Sun Z; Wang Y; Su B; Zhang C; Cao H; Liu X
Int J Biol Macromol; 2020 May; 151():312-321. PubMed ID: 32084462
[TBL] [Abstract][Full Text] [Related]
6. Direct Immobilization of Engineered Nanobodies on Gold Sensors.
Simões B; Guedens WJ; Keene C; Kubiak-Ossowska K; Mulheran P; Kotowska AM; Scurr DJ; Alexander MR; Broisat A; Johnson S; Muyldermans S; Devoogdt N; Adriaensens P; Mendes PM
ACS Appl Mater Interfaces; 2021 Apr; 13(15):17353-17360. PubMed ID: 33845569
[TBL] [Abstract][Full Text] [Related]
7. Correlation between the binding affinity and the conformational entropy of nanobody SARS-CoV-2 spike protein complexes.
Mikolajek H; Weckener M; Brotzakis ZF; Huo J; Dalietou EV; Le Bas A; Sormanni P; Harrison PJ; Ward PN; Truong S; Moynie L; Clare DK; Dumoux M; Dormon J; Norman C; Hussain N; Vogirala V; Owens RJ; Vendruscolo M; Naismith JH
Proc Natl Acad Sci U S A; 2022 Aug; 119(31):e2205412119. PubMed ID: 35858383
[TBL] [Abstract][Full Text] [Related]
8. NanoBERTa-ASP: predicting nanobody paratope based on a pretrained RoBERTa model.
Li S; Meng X; Li R; Huang B; Wang X
BMC Bioinformatics; 2024 Mar; 25(1):122. PubMed ID: 38515052
[TBL] [Abstract][Full Text] [Related]
9. Structural evaluation of EGFR inhibition mechanisms for nanobodies/VHH domains.
Schmitz KR; Bagchi A; Roovers RC; van Bergen en Henegouwen PM; Ferguson KM
Structure; 2013 Jul; 21(7):1214-24. PubMed ID: 23791944
[TBL] [Abstract][Full Text] [Related]
10. Allosteric Determinants of the SARS-CoV-2 Spike Protein Binding with Nanobodies: Examining Mechanisms of Mutational Escape and Sensitivity of the Omicron Variant.
Verkhivker G
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216287
[TBL] [Abstract][Full Text] [Related]
11. Kinetic and thermodynamic insights into interaction of erlotinib with epidermal growth factor receptor: Surface plasmon resonance and molecular docking approaches.
Mohammadzadeh-Asl S; Aghanejad A; Yekta R; de la Guardia M; Ezzati Nazhad Dolatabadi J; Keshtkar A
Int J Biol Macromol; 2020 Nov; 163():954-958. PubMed ID: 32653374
[TBL] [Abstract][Full Text] [Related]
12. Structural insights into a high affinity nanobody:antigen complex by homology modelling.
Skottrup PD
J Mol Graph Model; 2017 Sep; 76():305-312. PubMed ID: 28779687
[TBL] [Abstract][Full Text] [Related]
13. ModiBodies: A computational method for modifying nanobodies in nanobody-antigen complexes to improve binding affinity and specificity.
Hacisuleyman A; Erman B
J Biol Phys; 2020 Jun; 46(2):189-208. PubMed ID: 32418062
[TBL] [Abstract][Full Text] [Related]
14. Molecular determinants of epidermal growth factor binding: a molecular dynamics study.
Sanders JM; Wampole ME; Thakur ML; Wickstrom E
PLoS One; 2013; 8(1):e54136. PubMed ID: 23382875
[TBL] [Abstract][Full Text] [Related]
15. Identification of conformation-selective nanobodies against the membrane protein insertase BamA by an integrated structural biology approach.
Kaur H; Hartmann JB; Jakob RP; Zahn M; Zimmermann I; Maier T; Seeger MA; Hiller S
J Biomol NMR; 2019 Jul; 73(6-7):375-384. PubMed ID: 31073665
[TBL] [Abstract][Full Text] [Related]
16. Generation of Photocaged Nanobodies for Intracellular Applications in an Animal Using Genetic Code Expansion and Computationally Guided Protein Engineering.
O'Shea JM; Goutou A; Brydon J; Sethna CR; Wood CW; Greiss S
Chembiochem; 2022 Aug; 23(16):e202200321. PubMed ID: 35731601
[TBL] [Abstract][Full Text] [Related]
17. Engineered high-affinity nanobodies recognizing staphylococcal Protein A and suitable for native isolation of protein complexes.
Fridy PC; Thompson MK; Ketaren NE; Rout MP
Anal Biochem; 2015 May; 477():92-4. PubMed ID: 25707320
[TBL] [Abstract][Full Text] [Related]
18. Diversity in kinetics correlated with structure in nano body-stabilized LacY.
Kumar H; Finer-Moore J; Smirnova I; Kasho V; Pardon E; Steyaert J; Kaback HR; Stroud RM
PLoS One; 2020; 15(5):e0232846. PubMed ID: 32380514
[TBL] [Abstract][Full Text] [Related]
19. Binding affinity prediction of nanobody-protein complexes by scoring of molecular dynamics trajectories.
Soler MA; Fortuna S; de Marco A; Laio A
Phys Chem Chem Phys; 2018 Jan; 20(5):3438-3444. PubMed ID: 29328338
[TBL] [Abstract][Full Text] [Related]
20. Effect of hydrophobic and hydrogen bonding interactions on the potency of ß-alanine analogs of G-protein coupled glucagon receptor inhibitors.
Venugopal PP; Das BK; Soorya E; Chakraborty D
Proteins; 2020 Feb; 88(2):327-344. PubMed ID: 31443129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
